FREE SHIPPING ON ORDERS OVER $150

bso cancer treatment glutathione Buthionine sulfoximine, an inhibitor of biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF-κB and MAPK signaling pathways Catabolism of extracellular glutathione supplies

$27.46

Quantity
- +
Description

Journal of Molecular and Cellular Cardiology, 157, 3144

bso cancer treatment glutathione Buthionine sulfoximine, an inhibitor of biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF-B and MAPK signaling pathways Catabolism of extracellular glutathione supplies

doi: 10.1007/s00404-012-2237-2 16 TeedeHJTayCTLavenJJEDokrasAMoranLJPiltonenTTet al

bso cancer treatment glutathione Buthionine sulfoximine, an inhibitor of biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF-B and MAPK signaling pathways Catabolism of extracellular glutathione supplies

Trindade, S

bso cancer treatment glutathione Buthionine sulfoximine, an inhibitor of biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF-B and MAPK signaling pathways Catabolism of extracellular glutathione supplies

Recommended Frequency: Weekly or bi-weekly for 6-12 weeks

bso cancer treatment glutathione Buthionine sulfoximine, an inhibitor of biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF-B and MAPK signaling pathways Catabolism of extracellular glutathione supplies

You may also like

recommand products